Advertisement

S.Korea to secure Covid-19 vaccines for 88% of population

Follow The Hawk on Google News+ Follow

Advertisement


Seoul: The South Korean Health Ministry on Tuesday announced that it has planned to secure Covid-19 vaccines from foreign drugmakers for 44 million people, or 88 pecent of the country's total population.

In a statement, the Ministry said it pre-ordered 20 million doses of vaccines each from Pfizer, Moderna and AstraZeneca, which require two shots, as well as 4 million doses of vaccines from Johnson & Johnson's Janssen that require one shot for the country's 34 million people, reports Xinhua news agency.

Advertisement

The pre-order contract was formally signed with AstraZeneca, while other contracts planned to be inked in the near future, the ministry said.

Also readFSSAI to initiate action against Bisleri over unsafe water sample

The remaining vaccines for 10 million people will be secured through the World Health Organization's (WHO) global vaccine project, called COVAX Facility.

The government set aside a combined 1.3 trillion won ($1.2 billion) of the budget for the vaccine purchase.

Advertisement

The pre-ordered vaccines will be shipped to the country from February next year in a gradual way.

Also read'Fatty liver-free campaign' in Ranchi from Nov 23, MoS Sanjay Seth to take lead

If necessary, the country will secure additional vaccines according to the development of other vaccine candidates, according to the Ministry.

The Ministry said it has not decided on the vaccination schedule give that the vaccine development had yet to be completed while concerns remained over their safety and efficacy.

The government was considering the first inoculation of virus-vulnerable people, such as the elderly, nursing home residents and the chronically ill, as well as healthcare workers.

–IANS

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST